Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19214555 | 0.83 | EPHX2 (0.30) | EPHX2 | |
| SCHEMBL19214561 | 0.83 | EPHX2 (0.30) | EPHX2 | |
| SCHEMBL952944 | 0.81 | LMNA (0.35) | EPHX2LMNAALDH1A1MAPTMAPK1 | |
| SCHEMBL949988 | 0.80 | ALDH1A1 (0.34) | EPHX2LMNAALDH1A1MAPTMAPK1 | |
| SCHEMBL952118 | 0.80 | EPHX2 (0.36) | EPHX2LMNAALDH1A1MAPTMAPK1 | |
| SCHEMBL12332558 | 0.79 | EPHX2 (0.34) | EPHX2LMNAALDH1A1MAPTMAPK1 | |
| SCHEMBL19220816 | 0.76 | — | — | |
| SCHEMBL19214604 | 0.76 | MEN1 (0.32) | LMNAALDH1A1L3MBTL1 | |
| SCHEMBL952700 | 0.75 | ALDH1A1 (0.34) | EPHX2LMNAALDH1A1MAPTMAPK1 | |
| SCHEMBL106195 | 0.75 | EPHX2 (0.33) | EPHX2LMNAALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170226252-A1 | MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226252-A1 | MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | PARG, SMARCA1, SMARCA2 | EPHX2 196/4885LMNA 1043/4885ALDH1A1 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.